Hemostatic efficacy, safety, and pharmacokinetics of a recombinant von Willebrand factor in severe von Willebrand disease

This phase 3 trial evaluated the safety and hemostatic efficacy of a recombinant von Willebrand factor (rVWF) for treatment of bleeds in severe von Willebrand disease (VWD). rVWF was initially administered together with recombinant factor VIII (rFVIII) and subsequently alone, as long as hemostatic f...

詳細記述

保存先:
書誌詳細
出版年:Blood
主要な著者: Gill, Joan C., Castaman, Giancarlo, Windyga, Jerzy, Kouides, Peter, Ragni, Margaret, Leebeek, Frank W. G., Obermann-Slupetzky, Ortrun, Chapman, Miranda, Fritsch, Sandor, Pavlova, Borislava G., Presch, Isabella, Ewenstein, Bruce
フォーマット: Artigo
言語:Inglês
出版事項: American Society of Hematology 2015
主題:
Thrombosis and Hemostasis
オンライン･アクセス:https://ncbi.nlm.nih.gov/pmc/articles/PMC4616237/
https://ncbi.nlm.nih.gov/pubmed/26239086
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/blood-2015-02-629873
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!

類似資料